Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

Also called NCT07022249

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07022249
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07022249. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06 (anticipated); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms
Condition
Intracranial Aneurysms
Intervention (Device)
Intrasaccular Embolization Device
Lead sponsor
Ton-Bridge Medical Tech. Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct07022249
Content hash
9fcc4d7b9098bbf9df620457cacfd90892e05b1ed004cf63f8c5f72fa8e8da9a